Search

everythinglearnresearchcommunity

for

Search:↓

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

The new assay can help develop products for hair re-growth.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Allopregnanolone may enhance alcohol's effects on dopamine neurons, influencing addiction risk.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

Ginsenoside Rf from Panax ginseng promotes hair growth and could be a natural alternative for treating hair loss.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

The treatment effectively promotes hair regrowth in androgenetic alopecia without causing skin irritation.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

GD-23 reduces anxiety by relying on neurosteroid production.

Upadacitinib effectively treats pyoderma gangrenosum.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

PDRN helps repair tissue and improve wound healing with a high safety profile.

The new nasal gel for schizophrenia improved drug absorption and brain effects in rats.

Ginsenoside Rg3 from Panax ginseng can lighten skin by reducing melanin production.

Gingerol may help treat chronic graft-versus-host disease by improving immune cell balance.